GLASS-ART Trial

NA
NA
Canada

Phone: (888) 267-0707 option 1

Description:

The GLASS-ART Trial is a Phase III clinical trial testing Neuradiab™. Neuradiab™ is an investigational drug currently in the clinical testing process established by the U.S. Food and Drug Administration (FDA) for the evaluation of new drugs. This investigational medication is available through a formal clinical trial to treat glioblastoma multiforme (GBM).